Literature DB >> 20332481

Effect of YB-1 on the regulation of micro RNA expression in drug-sensitive and drug-resistant gastric carcinoma cells.

Elisa Belian1, Reka Kurucz, Denise Treue, Hermann Lage.   

Abstract

The multifunctional Y-Box protein 1 (YB-1) exerts positive and negative regulatory effects on gene expression by different mechanisms. Since transcription can be controlled by micro RNAs (miRNAs), YB-1 could also cause effects on gene expression by regulation of cellular miRNAs. To test this hypothesis, a previously established and well-characterized cell model derived from drug-sensitive (EPG85-257P/tetR/YB-1) and multidrug-resistant (EPG85-257RDB/tetR/YB-1) gastric carcinoma cells, in which the expression of YB-1 can be inhibited by tetracycline-dependent triggering of the RNA interference (RNAi) pathway, was investigated concerning their miRNA expression profiles in the presence and absence of YB-1. Microarray hybridizations demonstrated that six miRNAs (miR-96*, miR-210, miR-503, miR-623, miR-1275, miR-1290) were up-regulated more than 1.5-fold in drug-sensitive cells following YB-1 inhibition, but no differences in miRNA expression could be detected in multidrug-resistant cells. Independent validation of these findings by quantitative real-time reverse transcriptase polymerase chain reaction did not confirm these effects. Likewise, an in silico analysis of potential regulatory effects of the miRNAs on their target genes did not support the potential miRNA regulatory effects of YB-1. In conclusion, the data provide evidence that YB-1 has no direct influence on global miRNA expression pattern in different variants of gastric carcinoma cells and, therewith, does not control gene expression by regulation of miRNAs.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20332481

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  10 in total

1.  Integrative analysis of microRNA and mRNA expression profiles in non-small-cell lung cancer.

Authors:  C Yang; C Sun; X Liang; S Xie; J Huang; D Li
Journal:  Cancer Gene Ther       Date:  2016-03-11       Impact factor: 5.987

2.  Profiling analysis of circulating microRNA expression in cervical cancer.

Authors:  Yuzo Nagamitsu; Hirotaka Nishi; Toru Sasaki; Yotaro Takaesu; Fumitoshi Terauchi; Keiichi Isaka
Journal:  Mol Clin Oncol       Date:  2016-04-25

3.  miR-1290 is a potential prognostic biomarker in non-small cell lung cancer.

Authors:  Dongping Mo; Bing Gu; Xue Gong; Lei Wu; Hong Wang; Ye Jiang; Bingfeng Zhang; Meijuan Zhang; Yan Zhang; Jian Xu; Shiyang Pan
Journal:  J Thorac Dis       Date:  2015-09       Impact factor: 2.895

4.  MicroRNAs up-regulated by CagA of Helicobacter pylori induce intestinal metaplasia of gastric epithelial cells.

Authors:  Yongliang Zhu; Qiaoli Jiang; Xiaojun Lou; Xiaowei Ji; Zhenzhen Wen; Jia Wu; Haiying Tao; Tingting Jiang; Wei He; Caihua Wang; Qin Du; Shu Zheng; Jianshan Mao; Jian Huang
Journal:  PLoS One       Date:  2012-04-20       Impact factor: 3.240

5.  Immunohistochemical determination of the miR-1290 target arylamine N-acetyltransferase 1 (NAT1) as a prognostic biomarker in breast cancer.

Authors:  Yumi Endo; Hiroko Yamashita; Satoru Takahashi; Shinya Sato; Nobuyasu Yoshimoto; Tomoko Asano; Yukari Hato; Yu Dong; Yoshitaka Fujii; Tatsuya Toyama
Journal:  BMC Cancer       Date:  2014-12-20       Impact factor: 4.430

6.  miR-1290 Is a Biomarker in DNA-Mismatch-Repair-Deficient Colon Cancer and Promotes Resistance to 5-Fluorouracil by Directly Targeting hMSH2.

Authors:  Ling Ye; Tao Jiang; Huanzhang Shao; Lin Zhong; Zhaowen Wang; Yuan Liu; Huamei Tang; Bingyu Qin; Xiaoqing Zhang; Junwei Fan
Journal:  Mol Ther Nucleic Acids       Date:  2017-05-12

7.  Elevated nuclear YBX1 expression and the clinicopathological characteristics of patients with solid tumors: a meta-analysis.

Authors:  Chunze Zhang; Tingting Yin; Ran Tao; Bo Xiao; Jing Chen; Zixuan Li; Xueyuan Miao; Qing Peng; Liu Sun; Weihua Zhang; Junxu Ren; Zhao Zhang; Ying Zhang; Xichuan Li; Wei Zhang
Journal:  Cancer Manag Res       Date:  2019-05-14       Impact factor: 3.989

8.  Development and clinical validation of a 3-miRNA signature to predict prognosis of gastric cancer.

Authors:  Wenqian Qi; Qian Zhang
Journal:  PeerJ       Date:  2021-02-03       Impact factor: 2.984

9.  Links between the oncoprotein YB-1 and small non-coding RNAs in breast cancer.

Authors:  Cherie Blenkiron; Daniel G Hurley; Sandra Fitzgerald; Cristin G Print; Annette Lasham
Journal:  PLoS One       Date:  2013-11-18       Impact factor: 3.240

10.  YB1 regulates miR-205/200b-ZEB1 axis by inhibiting microRNA maturation in hepatocellular carcinoma.

Authors:  Xiumei Liu; Di Chen; Huan Chen; Wen Wang; Yu Liu; Yawei Wang; Chao Duan; Zhen Ning; Xin Guo; Wuxiyar Otkur; Jing Liu; Huan Qi; Xiaolong Liu; Aifu Lin; Tian Xia; Hong-Xu Liu; Hai-Long Piao
Journal:  Cancer Commun (Lond)       Date:  2021-06-10
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.